Clinical trial
Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19
NCT04979221 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 26, 2021
- Completion date
- February 28, 2022
- Enrollment
- 274 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 pneumonia